Electrophysiological abnormalities in iatrogenic botulism: Two case reports and review of the literature

J Clin Neurosci. 2019 Feb:60:138-141. doi: 10.1016/j.jocn.2018.10.059. Epub 2018 Oct 19.

Abstract

Therapeutic use of botulinum neurotoxin type A (BoNT/A) is effective, and generally safe. Nevertheless, iatrogenic botulism (IB) is rarely reported as a result of systemic spread of the BoNT/A, causing general weakness, bulbar symptoms and dysautonomia. Suggestive clinical feature are decisive to raise the diagnostic suspicion, which however needs a confirmation in the electrodiagnostic (EDX) study, above all to exclude other treatable diseases. In this study, we report 2 patients who developed IB after receiving therapeutic doses of BoNT/A, assessing the EDX changes, and reviewing the literature on EDX in IB. Although there is not enough data to draw solid conclusions we propose that, in a subject with suggestive clinical features and recent exposure to BoNT/A, the absence of a decremental or incremental response to repetitive nerve stimulation in muscles showing acute denervation changes, is a suggestive finding for the diagnosis of IB.

Keywords: Botulinum neurotoxin type/A; Electrophysiological abnormalities; Iatrogenic botulism.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Botulinum Toxins, Type A / adverse effects*
  • Botulism / diagnosis*
  • Botulism / etiology*
  • Botulism / physiopathology
  • Cerebral Palsy / complications
  • Electrophysiology
  • Female
  • Humans
  • Iatrogenic Disease
  • Male
  • Middle Aged
  • Multiple Sclerosis / complications
  • Muscle Spasticity / drug therapy
  • Muscle Spasticity / etiology
  • Neurologic Examination

Substances

  • Botulinum Toxins, Type A